Fuula Jalqabaa › Tajaajiltoota › Cerevel Therapeutics, LLC
Cerevel Therapeutics, LLC: Baajannaa H-1B fi deggera
Cerevel Therapeutics, LLC iyyannoo hojii haala 7 H-1B fi viizaa walitti dhufeenya qaban bara maallaqaa 2023–2026 irratti galche; mirkaneessame: 7. Baajannaa giddugaleessaa dhiyaate: $139,000.
Cerevel Therapeutics, LLC viizaa H-1B deggeraa?
Cerevel Therapeutics, LLC bara maallaqaa 2023–2026 irratti iyyannoo hojii haala 7 galche, kan haaraan 12-Ado-2024 irratti dhiyaate. LCA tarsiimoo jalqabaa iyyannoo H-1B ti, hojii kennaan hojjettoota H-1B deggereera yookaan deggeruuf qophii ta'eera; hojii adda addaaf deggera hin mirkaneessu. Galmee hojii hojii kennaa isaa ilaali.
Baajannaa maqaa hojii irratti
| Mata-duree hojii | LCAs | Baasii giddu-galeessaa |
|---|---|---|
| Principal Analyst, Clinical Programming | 2 | $139,500 |
| Principal Scientist, Formulation Development | 2 | $130,500 |
| Senior Director, Medical Affairs | 1 | $300,000 |
| Senior Manager, Clinical Pharmacology | 1 | $180,000 |
| Research Scientist, Formulation Development | 1 | $120,119 |
Iyyannoo bara maallaqaa irratti
| Bara maallaqaa | LCAs | Baasii giddu-galeessaa |
|---|---|---|
| FY2023 | 4 | $159,500 |
| FY2024 | 3 | $130,000 |
Sadarkaa baajannaa olaanaa
Dhaabbanni Hojii sadarkaa baajannaa olaanaa afur hojii tokkoo tokkoo fi bakkaaf, Sadarkaa I (jalqabaa) hanga Sadarkaa IV (guddisaa) jiru, kaa'a. Hojii kennaan sadarkaa hojii sanaaf madaalu filata.
Hojiiwwan eessa jiru
Hojiiwwan
- Chemists3
- Molecular and Cellular Biologists2
- Medical and Health Services Managers1
- Medical Scientists, Except Epidemiologists1
Iyyannoo haaraa
| Mata-duree hojii | Baasii bu'uuraa | Bakka | Dhiyaate | Guyyaa jalqabaa | Haala |
|---|---|---|---|---|---|
| Principal Scientist, Formulation Development | $130,000–$166,000 Sadarkaa IV | Somerset, NJ | 12-Ado-2024 | 29-Ado-2024 | Mirkaneffame |
| Principal Analyst, Clinical Programming | $140,000–$163,000 Sadarkaa III | Larenceville, NJ | 04-Wax-2024 | 17-Wax-2024 | Mirkaneffame |
| Research Scientist, Formulation Development | $120,119–$138,000 | Cambridge, MA | 24-Elb-2024 | 01-Onk-2024 | Mirkaneffame |
| Senior Manager, Clinical Pharmacology | $180,000–$191,113 Sadarkaa IV | Cambridge, MA | 28-Wax-2023 | 17-Ado-2023 | Mirkaneffame |
| Principal Analyst, Clinical Programming | $139,000–$164,000 Sadarkaa III | Cambridge, MA | 17-Bit-2023 | 10-Elb-2023 | Mirkaneffame |
| Principal Scientist, Formulation Development | $131,000–$168,000 Sadarkaa III | Cambridge, MA | 26-Mud-2022 | 30-Ama-2023 | Mirkaneffame |
| Senior Director, Medical Affairs | $300,000–$350,000 Sadarkaa IV | Cambridge, MA | 30-Wax-2022 | 18-Ado-2022 | Mirkaneffame, erga haqamee |
Baajanni gatii gadii gatii hojii iyyannoo tokkoo tokkoon irratti dhiyaate yoo ta'u, gara baajannaa waggaatti jijjiirame; lakkoofsa hojii guutuu hamma guyyaa guutuu qofa fayyadama. LCA mirkaneessa viizaa miti; LCA tokko hojii hedduu haguuchuuf ni danda'a. Madda: Dhaabbata Hojii Ameerikaa, OFLC LCA Disclosure Data, bara maallaqaa 2023–2026 (murtii haaraa 30-Wax-2026).